A pharmaceutically acceptable salt of a condensed furan compound
PK139964AUndetermined Publication Date: 2009-02-10TANABE PHARMA CORP
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200601306
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2009-02-10
Abstract
wherein Ring X is benzene, pyridine, or the like; Y is an optionally substituted amino, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted saturated heterocyclic group, an optionally substituted unsaturated heterocyclic group; A is a single bond, lower alkylene, lower alkenylidene, lower alkenylene or an oxygen atom; R3 is hydrogen or the like; and , R4 is hydrogen, or the like, which is useful as a medicament, particularly, as an activated blood coagulation factor X inhibitor.
Need to check novelty before this filing date? Find Prior Art
